About Progressive encephalopathy with leukodystrophy due to DECR deficiency
Progressive encephalopathy with leukodystrophy due to DECR deficiency is a rare disease catalogued by Orphanet (ORPHA:431361). It is associated with the NADK2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Progressive encephalopathy with leukodystrophy due to DECR deficiency trials.
Search ClinicalTrials.gov for "Progressive encephalopathy with leukodystrophy due to DECR deficiency" or filter by Orphanet code ORPHA:431361 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Progressive encephalopathy with leukodystrophy due to DECR deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Progressive encephalopathy with leukodystrophy due to DECR deficiency. Updated daily.